Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-110,934
Closed -$377K 1863
2024
Q2
$377K Sell
110,934
-197,741
-64% -$647K ﹤0.01% 1895
2024
Q1
$935K Hold
308,675
﹤0.01% 1799
2023
Q4
$1.3M Sell
308,675
-73,171
-19% -$397K ﹤0.01% 1837
2023
Q3
$2.61M Sell
381,846
-31,890
-8% -$282K ﹤0.01% 1799
2023
Q2
$4.31M Sell
413,736
-1,200,000
-74% -$10.7M ﹤0.01% 1753
2023
Q1
$11.2M Buy
1,613,736
+1,122,838
+229% +$9.79M ﹤0.01% 1536
2022
Q4
$2.96M Hold
490,898
﹤0.01% 1912
2022
Q3
$3.87M Sell
490,898
-66,970
-12% -$781K ﹤0.01% 1816
2022
Q2
$7.59M Buy
557,868
+51,706
+10% +$855K ﹤0.01% 1661
2022
Q1
$9.93M Buy
506,162
+33,200
+7% +$663K ﹤0.01% 1704
2021
Q4
$16.2M Buy
472,962
+104,556
+28% +$4.21M ﹤0.01% 1575
2021
Q3
$20.1M Buy
368,406
+40,962
+13% +$2.47M ﹤0.01% 1482
2021
Q2
$24.1M Sell
327,444
-163,344
-33% -$16.3M 0.01% 1426
2021
Q1
$44.9M Buy
+490,788
New +$47.6M 0.01% 1038

Other funds holding CVAC

Norges Bank's CVAC Position: Q3 2024 in Review

Norges Bank sold out of CureVac (CVAC) in Q3 2024, closing a stake of 110,934 shares — an estimated $377K sold.

Norges Bank first reported a position in CVAC in Q1 2021 and held it in 14 quarters. The position peaked at $44.9M in Q1 2021. 81 funds tracked by Wall St. Rank hold CVAC as of Q3 2024.

  • Norges Bank reported no remaining CureVac position as of Q3 2024 after selling out during the quarter.
  • Norges Bank sold 110,934 CureVac shares in Q3 2024, an estimated $377K.
  • Norges Bank first reported a position in CureVac in Q1 2021 and held it in 14 quarters.
  • Norges Bank's CureVac position peaked at $44.9M in Q1 2021.
  • 81 funds tracked by Wall St. Rank held CureVac as of Q3 2024.

Based on Norges Bank's 13F filing for Q3 2024, filed 13 Nov 2024.